{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:44:54Z","timestamp":1788896694906,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The sigma-2 receptor was originally defined pharmacologically and recently identified as TMEM97. TMEM97 has been validated as a biomarker of proliferative status and the radioligand of TMEM97, [18F]ISO-1, has been developed and validated as a PET imaging biomarker of proliferative status of tumors and as a predictor of the cancer therapy response. [18F]ISO-1 PET imaging should be useful to guide treatment for cancer patients. TMEM97 is a membrane-bound protein and localizes in multiple subcellular organelles including endoplasmic reticulum and lysosomes. TMEM97 plays distinct roles in cancer. It is reported that TMEM97 is upregulated in some tumors but downregulated in other tumors and it is required for cell proliferation in certain tumor cells. TMEM97 plays important roles in cholesterol homeostasis. TMEM97 expression is regulated by cholesterol-regulating signals such as sterol depletion and SREBP expression levels. TMEM97 regulates cholesterol trafficking processes such as low density lipoprotein (LDL) uptake by forming complexes with PGRMC1 and low density lipoprotein receptor (LDLR), as well as cholesterol transport out of lysosome by interacting with and regulating NPC1 protein. Understanding molecular functions of TMEM97 in proliferation and cholesterol metabolism will be important to develop strategies to diagnose and treat cancer and cholesterol disorders using a rich collection of TMEM97 radiotracers and ligands.<\/jats:p>","DOI":"10.3390\/cancers12071877","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T11:03:23Z","timestamp":1594724603000},"page":"1877","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The Biological Function of Sigma-2 Receptor\/TMEM97 and Its Utility in PET Imaging Studies in Cancer"],"prefix":"10.3390","volume":"12","author":[{"given":"Chenbo","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-446X","authenticated-orcid":false,"given":"Aladdin","family":"Riad","sequence":"additional","affiliation":[{"name":"Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Mach","sequence":"additional","affiliation":[{"name":"Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"ref_1","first-page":"517","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_2","unstructured":"Su, T.-P., Matsumoto, R.R., and Bowen, W.D. (2007). \u03c3 Receptors: Historical perspective and background. Sigma Receptors: Chemistry, Cell Biology and Clinical Implications, Springer."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(90)91143-5","article-title":"A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain","volume":"527","author":"Hellewell","year":"1990","journal-title":"Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: Characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.tips.2019.07.006","article-title":"The Molecular Function of sigma Receptors: Past, Present, and Future","volume":"40","author":"Schmidt","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the sigma2 receptor","volume":"114","author":"Alon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ncomms1386","article-title":"Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site","volume":"2","author":"Xu","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.ebiom.2015.10.017","article-title":"The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes","volume":"2","author":"Chu","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.12.023","article-title":"Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1","volume":"117","author":"Pati","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-35430-3","article-title":"Sigma-2 Receptor\/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex","volume":"8","author":"Riad","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1054\/bjoc.1999.1067","article-title":"Sigma-2 receptors as a biomarker of proliferation in solid tumours","volume":"82","author":"Wheeler","year":"2000","journal-title":"Br. J. Cancer"},{"key":"ref_13","first-page":"156","article-title":"Sigma 2 receptors as potential biomarkers of proliferation in breast cancer","volume":"57","author":"Mach","year":"1997","journal-title":"Cancer Res."},{"key":"ref_14","first-page":"65","article-title":"Murine mammary tumour cells in vitro. I. The development of a quiescent state","volume":"17","author":"Wallen","year":"1984","journal-title":"Cell Tissue Kinet."},{"key":"ref_15","first-page":"79","article-title":"Murine mammary tumour cells in vitro. II. Recruitment of quiescent cells","volume":"17","author":"Wallen","year":"1984","journal-title":"Cell Tissue Kinet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bjc.6690789","article-title":"Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells","volume":"81","author":"Mach","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_17","unstructured":"Kim, F.J., and Pasternak, G.W. (2017). Molecular probes for imaging the sigma-2 receptor: In vitro and in vivo imaging studies. Sigma Proteins: Evolution of the Concept of Sigma Receptors, Springer International Publishing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1021\/jm301545c","article-title":"The sigma2 receptor: A novel protein for the imaging and treatment of cancer","volume":"56","author":"Mach","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2967\/jnumed.112.111948","article-title":"Assessment of cellular proliferation in tumors by PET using 18F-ISO-1","volume":"54","author":"Dehdashti","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"McDonald, E.S., Doot, R.K., Young, A.J., Schubert, E.K., Pryma, D.A., Farwell, M.D., Tchou, J., Nayak, A., Ziober, A., and Feldman, M.D. (2019). Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status. J. Nucl. Med.","DOI":"10.2967\/jnumed.119.232363"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shoghi, K.I., Xu, J., Su, Y., He, J., Rowland, D., Yan, Y., Garbow, J.R., Tu, Z., Jones, L.A., and Higashikubo, R. (2013). Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074188"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1634\/theoncologist.2017-0072","article-title":"Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results","volume":"22","author":"Loibl","year":"2017","journal-title":"Oncologist"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1158\/1078-0432.CCR-18-2769","article-title":"Cell-Proliferation Imaging for Monitoring Response to CDK4\/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [(18)F]FLT and [(18)F]ISO-1 PET\/CT","volume":"25","author":"Elmi","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_24","first-page":"408","article-title":"Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines","volume":"55","author":"Vilner","year":"1995","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2004.04.005","article-title":"Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes","volume":"493","author":"Gebreselassie","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1158\/0008-5472.CAN-06-3803","article-title":"Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy","volume":"67","author":"Zeng","year":"2007","journal-title":"Cancer Res."},{"key":"ref_27","first-page":"1021","article-title":"Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract","volume":"19","author":"Kayed","year":"2004","journal-title":"Histol. Histopathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000331716","article-title":"Significance of mRNA and protein expression of MAC30 in progression of colorectal cancer","volume":"57","author":"Zhao","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000106449","article-title":"Expression of MAC30 in rectal cancers with or without preoperative radiotherapy","volume":"71","author":"Zhang","year":"2006","journal-title":"Oncology"},{"key":"ref_30","first-page":"91","article-title":"Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers","volume":"30","author":"Moparthi","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2478\/v10019-011-0030-7","article-title":"Expression of NF-kappaB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy","volume":"45","author":"Lewander","year":"2011","journal-title":"Radiol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1533034616670443","article-title":"The Prognostic Effect of MAC30 Expression on Patients with Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy","volume":"16","author":"Ding","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2217\/fon-2017-0426","article-title":"The prognostic role of MAC30 in advanced gastric cancer patients receiving platinum-based chemotherapy","volume":"13","author":"Wu","year":"2017","journal-title":"Future Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jso.23269","article-title":"Expression of MAC30 protein is related to survival and clinicopathological variables in breast cancer","volume":"107","author":"Xiao","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12032-012-0324-7","article-title":"Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer","volume":"30","author":"Yang","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13148-018-0475-2","article-title":"A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97","volume":"10","author":"Goncalves","year":"2018","journal-title":"Clin. Epigenet."},{"key":"ref_37","first-page":"715","article-title":"Identification and characterization of genes differentially expressed in meningiomas","volume":"4","author":"Murphy","year":"1993","journal-title":"Cell Growth Differ."},{"key":"ref_38","first-page":"1888","article-title":"Down-regulated MAC30 expression inhibits breast cancer cell invasion and EMT by suppressing Wnt\/beta-catenin and PI3K\/Akt signaling pathways","volume":"12","author":"Qu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1007\/s13277-015-3552-6","article-title":"RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells","volume":"36","author":"Qiu","year":"2015","journal-title":"Tumour. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1159\/000358703","article-title":"Down-regulated MAC30 expression inhibits proliferation and mobility of human gastric cancer cells","volume":"33","author":"Xu","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wilcox, C.B., Feddes, G.O., Willett-Brozick, J.E., Hsu, L.C., DeLoia, J.A., and Baysal, B.E. (2007). Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: Implications for pathogenesis of ovarian cancer. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-223"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0006-291X(02)02751-1","article-title":"Identification of genes induced by BRCA1 in breast cancer cells","volume":"299","author":"Atalay","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","first-page":"383","article-title":"Detection of differentially expressed genes in human bladder cancer cells using arbitrarily primed PCR of RNA","volume":"11","author":"Maack","year":"1997","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41420-019-0141-2","article-title":"TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death","volume":"5","author":"Zeng","year":"2019","journal-title":"Cell Death Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2009.05.009","article-title":"Identification of cholesterol-regulating genes by targeted RNAi screening","volume":"10","author":"Bartz","year":"2009","journal-title":"Cell Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/hmg\/ddw204","article-title":"Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells","volume":"25","author":"Wahlster","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_47","first-page":"439","article-title":"TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease","volume":"5","author":"Ponting","year":"2014","journal-title":"Front Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.CCR-13-0122","article-title":"Molecular pathways: Sterols and receptor signaling in cancer","volume":"20","author":"Gabitova","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.1252787","article-title":"Cancer. Cholesterol and cancer, in the balance","volume":"343","author":"Poirot","year":"2014","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.4155\/fmc-2018-0072","article-title":"Sigma-2 receptor: Past, present and perspectives on multiple therapeutic exploitations","volume":"10","author":"Abate","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3389\/fphar.2019.01141","article-title":"Small-Molecule Modulators of Sigma1 and Sigma2\/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes","volume":"10","author":"Oyer","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/7\/1877\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:50:40Z","timestamp":1760176240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/7\/1877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["cancers12071877"],"URL":"https:\/\/doi.org\/10.3390\/cancers12071877","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]}}}